Conflicts of interest
Edema, Stroke
EDEMA, STROKE, BRAIN INFARCTION
D. Lehrieder, H.P. Müller, J. Kassubek, G. Thomalla, D. Michalski, T. Gattringer, K.E. Wartenberg, J. Schultze-Amberger, H. Huttner, J.B. Kuramatsu, S. Wunderlich, H.H. Steiner, K. Weissenborn, S. Heck, H. Schneider, C. Dohmen, J. Woitzik and H. Neugebauer report no disclosures relevant to the manuscript; N. Hecht is Berlin Institute of Health Clinical Fellow, funded by Stiftung Charité; S. Poli is coordinating investigator of Automatic PredICtion of Edema after Stroke (APICES) study (ClinicalTrials.gov unique identifier: NCT04057690); A. Günther reports honoria from Pfizer, Bristol-Myers-Squibb, Boeringer Ingelheim, Daiichi Sankyo, Occlutech, Ipsen Pharma and Merz outside the submitted work; E. Jüttler reports honoria from Pfizer, Bristol-Myers-Squibb, Boehringer Ingelheim, Daiichi Sankyo and Stryker outside the submitted work. He was Principle Investigator of DESTINY and DESTINY II, Co-Investigator of the pooled analyses of randomized hemicraniectomy trials and Co-author of guidelines on intracranial pressure treatment and treatment of space-occupying brain infarction.